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Abstract
Background: Obesity is increasing worldwide and weight-control strategies, including the consumption of plant
food supplements (PFS), are proliferating. This article identifies the herbal ingredients in PFS consumed for weight
control and by overweight/obese dieters in six European countries, and explores the relationship between their
consumption and their self-reported BMI.
Methods: Data used were a subset from the PlantLIBRA PFS Consumer Survey 2011-2012, a retrospective survey of
2359 PFS consumers. The survey used a bespoke frequency-of-PFS-usage questionnaire. Analyses were performed in
two consumer subsamples of 1) respondents taking the products for “body weight reasons”, and 2) “dieters for
overweight/obesity”, to identify the herbal ingredients consumed for these reasons. The relationship between the 5
most consumed herbal ingredients and self-reported BMI in groups 1 and 2 is explored by comparing BMI
proportions of consumers vs. non-consumers (using Chi-squared test).
Results: 252 PFS (8.8 %) were consumed for “body weight reasons” (by 240 PFS consumers); 112 PFS consumers
(4.8 %) were “dieting for overweight/obesity”. Spain is the country where consuming herbal ingredients for body
weight control and dieting were most popular. Artichoke was the most consumed herbal ingredient. Considering
only the 5 top products consumed by those who responded “body weight”, when using the total survey sample,
a greater proportion of BMI ≥ 25 was observed among consumers of PFS containing artichoke and green tea as
compared to non-consumers (58.4 % vs. 49.1 % and 63.2 % vs. 49.7 % respectively). Considering only the 5 top
products consumed by “dieters” and using only the “dieters” sample, a lower proportion of BMI≥ 25 was observed
among pineapple-containing PFS consumers (38.5 % vs. 81.5 %); however, when using the entire survey sample, a
greater proportion of BMI≥ 25 was observed among artichoke-containing PFS consumers (58.4 % vs. 49.1 %).
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Conclusions: A comparison of results among the scarce publications evaluating the use of weight-loss
supplements at the population level is limited. Nevertheless every hint is important in finding out which are the
self-treatment strategies used by overweight/obese individuals in European countries. Although limited by a
small sample size, our study represents a first attempt at analysing such data in six EU countries. Our findings
should encourage the conduction of further studies on this topic, long-term and large sample-sized studies,
ideally conducted in the general population.
Keywords: Weight control, Body mass index, PlantLIBRA survey, Plant food supplements, European
Background
Obesity is a global epidemic [1, 2] and consequently
many individuals are seeking strategies to reduce their
body weight and fat levels. These strategies may include
weight-loss food supplements, including plant food sup-
plements (PFS), such as appetite suppressants or those
increasing resting metabolism [3].
PFS that claim to contribute to weight loss are mar-
keted worldwide and readily available over the Internet
[4–6]. This increased usage has coincided with a resur-
gence of interest in nutritional therapy and complemen-
tary and alternative medicine (CAM) [7]; PFS and dietary
therapies for weight loss are among the most common
CAM modalities [8]. Various reasons underlie this prefer-
ence: the therapies are promoted as requiring less effort
than other behavioural changes (i.e. diet and exercise); are
heavily advertised with claims of effectiveness; are readily
available without a prescription [9]; are commonly mar-
keted on the Internet [10]; are believed to be “natural” and
“harmless”; and, at least in the EC countries, are regulated
as foods rather than medicines [11]. Moreover, there is no
perceived need for professional assistance with these strat-
egies and individuals who cannot afford to visit a phys-
ician often view PFS as a more accessible solution [12].
For many other individuals, these strategies represent al-
ternatives to failed attempts at losing weight using more
conventional approaches; these consumers are likely to
combine strategies or use these supplements at doses
higher than recommended [9, 12].
The fact that PFS used for weight loss do not require
rigorous safety controls before entering the market is
causing a serious public health problem, evidenced by
the increasing number of studies of hepatotoxicity from
their use worldwide [13–17]. However, these studies
have major methodological limitations that make it diffi-
cult to evaluate causality [17].
Actions are already been taken to tackle this problem
in countries with the highest consumption of weight-loss
supplements, such as the United States (US) or Japan
[18]. In the US, the National Institutes of Health (NIH)
committed substantial funding to dietary supplement re-
search in the financial years 2009–2011 with the object-
ive of expanding the scientific knowledge base on the
efficacy and safety of dietary supplements, with botani-
cals being the dietary supplement ingredients receiving
the most funding [19]. In Europe, the assessment of the
efficacy and safety of food supplements including herbal
ingredients is also being addressed, driven by the in-
creasing usage of these products [20–22].
The literature on weight-loss PFS and their individual
ingredients is extensive and includes reviews [17], ran-
domized controlled trials (RCTs) assessing the effective-
ness of these products [12, 23–26] or of individual
herbal ingredients (such as Phaseolus vulgaris [27].
Other available research includes RCTs that assess the
effectiveness/efficacy of individual herbal ingredients for
weight loss [28, 29] and their adverse effects [22, 23]; fi-
nally, other research has evaluated the availability of
weight-loss products (including herbals/botanicals) in
the local markets [30, 31].
However, very few surveys have addressed the use of
these particular products by consumers, with limited in-
formation on who is using them and which herbal ingre-
dients are included in the weight-loss PFS reported by
actual users. A number of multi-country, national, re-
gional or local surveillance surveys have asked about the
use of supplements [32–36], with some including sec-
tions on CAM and herbal supplements [37–42]. In spite
of this, the focus is not specifically on weight-loss herbal
supplements, but rather any supplement use, such as
vitamin and mineral use, or CAM use or the use of the
most commonly taken herbs to treat a specific health
condition [41]. At the European level, the recent Plan-
tLIBRA PFS Consumer Survey [43] is the first source of
user data available that has allowed an analysis on
weight-loss PFS in 6 European countries, and whose re-
sults are presented in the current paper.
Few studies on the use of herbal ingredients for
weight-loss have been identified, with the larger-scale
ones being conducted in the US. The most directly
related one used data from the 2002 National Phys-
ical Activity and Weight Loss Survey (final n = 9,403);
it assessed the prevalence and duration of non-
prescription weight-loss supplement use (8.7 % had
past year use, and use by adults with obesity was
substantially higher than that of normal-weight
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individuals), the associated weight-control behaviours,
the discussion of supplement use with a health care
professional, and specific ingredient use (73.8 % used
supplements containing a stimulant including ephedra,
caffeine, and/or bitter orange) [44]. Another US study
used data on CAM use from the 2002 National Health
Interview Survey (NHIS) Alternative Medicine Supple-
ment (n = 31,044) and compared the use of CAM overall,
within the previous year, between four categories of adult
BMI [45]. A third and smaller US study used data from a
2005–2006 nationally representative survey (n = 3,500
adults), and assessed dietary supplement use for weight
loss and perceptions of safety, efficacy and regulatory
oversight of these products [9]. Outside the US, a 2009
survey in the Polish city of Szczecin evaluated the range of
weight-loss programmes and behaviours associated with
the use of slimming supplements (appetite inhibitors or
fat burning and thermogenesis enhancers), observed
among 300 female university students [46]. The most re-
cent study was a cross-sectional population-based survey
conducted in 2,732 adults living in the Brazilian city of
Pelotas that aimed to determine the prevalence of
weight-loss practices and use of substances for weight-
loss during the 12 months preceding the interview [47].
Because weight-loss PFS usage data are very scarce,
with almost no data on the actual herbal ingredients
consumed, the objectives of this paper are two-fold: 1)
to identify the PFS herbal ingredients consumed for
weight loss and/or control in 6 European countries, and
2) to explore the relationship between the consumption
of these herbal ingredients and the self-reported BMI of
their consumers. A subset of data from the six-
European-country “PlantLIBRA PFS Consumer Survey
2011–2012” has been used.
Methods
Survey sample
This study was carried out within the PlantLIBRA pro-
ject (FP7-EC funded project n°245199). Data on PFS
usage were collected in Finland, Germany, Italy, Romania,
Spain and the United Kingdom, in a cross-sectional, retro-
spective survey of 2359 PFS consumers, using a bespoke
frequency-of-PFS-usage questionnaire. Further details of
the methodology of the survey (sampling, questionnaires,
data collection, databases, etc), and the concepts and defi-
nitions used, can be found in Garcia-Alvarez et al. [43].
Study samples
Analyses were performed on 3 subsamples of the Plan-
tLIBRA PFS Consumer Survey population: 1) PFS con-
sumers who responded to be taking the products for
“body weight reasons” (n = 240), when asked “For what
reason(s)/condition(s) did you take this product?”, 2) PFS
consumers who reported to be “dieting for overweight/
obesity” (n = 112), when asked “Please indicate the spe-
cial diet that you follow”, and 3) PFS consumers who
belonged to both subsamples 1 and 2 (n = 67), i.e. who
responded to take the product for “body weight reasons”
while “dieting for overweight/obesity”.
Variables
A number of variables were created and/or recoded in
the original data set [20] to facilitate reporting and ana-
lysis, including: 1) “body weight reason”, with two cat-
egories: “Responded body weight” (products taken for
“body weight”) and “Did not respond body weight”
(products not taken for “body weight”); 2) “dieting”, with
two categories: “dieting for overweight/obesity” (con-
sumers dieting for overweight/obesity) and “not dieting
for overweight/obesity” (consumers not dieting for over-
weight/obesity); 3) “BMI”, calculated from self-reported
weight and height, and for which WHO criteria [48]
were used to categorise individuals as “underweight-and-
normal weight” (BMI < 25 kg/m2) and “overweight-and-
obese” (BMI ≥ 25 kg/m2); 4) “education level”, defined as
low, medium, and high; 5) “employment status”, defined
as “currently employed” and “other groups”; 6) “physical
activity”, calculated using the short version of the IPAQ
[49] and defined as low, moderate or high; 7) “food fre-
quency”, defined as times/day of fruit, vegetables, bakery
and pastries, soft drinks and fast food.
Statistical analyses
The statistical package SPSS for Windows v. 18 (IBM Cor-
poration, Somers, NY, USA) was used for data analysis.
The subsamples of respondents and non-respondents
using PFS for body weight reasons were described in
terms of the above variables/characteristics, using both
Chi-squared and t tests for categorical and mean com-
parisons (p < 0.05 for significance). Frequencies and per-
centages for the variables “responded body weight reason”
and “dieting for overweight/obesity” were stratified by
country. Absolute frequencies, percentages and 95 % con-
fidence intervals for the top 20 herbal ingredients in prod-
ucts taken by respondents and non-respondents of body
weight reasons and by overweight/obesity dieters and
non-dieters were calculated, as well as those for the top 10
herbal ingredients in products taken by consumers who
responded body weight and who were simultaneously
dieting for overweight/obesity. For the purpose of this
paper, the frequency of an individual herbal ingredient
was defined as “the number of times that herbal ingredient
was found as ingredient in the total pooled number of PFS
consumed by all respondents of the subsamples”. More-
over, each herbal ingredient only counted once regardless
of the number of times it was consumed by a respondent.
Finally, it was not taken into account if the herbal ingredi-
ent came from a single- or multi-ingredient product, i.e.
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no “weight” was given to the particular herbal ingredient
within the product.
Chi-squared tests were used to test the relationship
between the 5 most consumed herbal ingredients and
self-reported BMI in subsamples 1 and 2, by comparing
BMI proportions of consumers vs. non-consumers of
these herbal ingredients (p < 0.05 for significance). Com-
parisons were made using a) subsample 1 and subsample
2 in which the top 5 consumed herbal ingredients were
actually identified (n = 240 and n = 112 respectively), and
b) the total survey PFS consumer sample (N = 2359), in
order to increase the power of the test. Finally, absolute
frequencies of the top herbal ingredient contained in the
consumed PFS were stratified by country.
It is important to bear in mind that when reporting
the results, the unit of analysis varies depending on the
variables used, i.e. for certain variables the unit is an in-
dividual respondent, for others it may change to the PFS
product level, or to the level of the herbal ingredient
contained in the product. Furthermore, data were not
weighted by the population size because of the study
methodology selected, whereby all country samples were
very similar in size and included only PFS consumers.
All results presented in the tables represent analysis of
the raw data.
Results
Characteristics of PFS users for reasons of body weight
and of PFS users for other reasons
Table 1 shows the characteristics of the overall survey
sample, and also of the subsample of consumers taking
PFS for “body weight reasons”. A prevalence of 10.2 %
users of PFS for body weight reasons was observed, whose
profile showed a higher proportion of: 1) females, 2) fe-
males aged 18–59, 3) individuals from Spain, 4) individuals
with a BMI ≥ 25, 5) individuals with a medium education
level, 6) currently employed individuals, 7) individuals who
are not on a diet for overweight/obesity (72.1 % vs. 27.9 %),
8) individuals with a low level of physical activity, 9) never
smokers -followed by current smokers, and of 10) individ-
uals that consume alcohol less than once a day. The differ-
ences are only significant in cases 1), 3), 4), 7–10). As for
food frequency, those who were not taking PFS for body
weight reasons had a higher mean consumption of pas-
tries/cakes and soft-drinks (times per day) as compared to
those using PFS for weight control.
Country distribution of products taken for body weight
reasons and of consumers dieting for overweight/obesity
Figure 1 shows that of the total 2874 PFS products re-
ported in the survey, 252 (8.8 %) products were being
consumed for body weight reasons (by 240 PFS con-
sumers), Spain being the country with the highest con-
sumption of PFS for this reason (21.5 %).
Figure 2 shows that of the total 2359 PFS consumers in
the survey, 112 (4.8 %) reported “dieting for overweight/
obesity”, Spain being the country with most dieters.
Herbal ingredients most consumed by respondents of
“body weight reasons”, “dieters for overweight/obesity”
and “dieters for overweight/obesity responding body
weight”
Tables 2 and 3 list the top 20 herbal ingredients con-
sumed by each of the two groups (subsamples 1 and 2),
and Table 4 lists the top 10 herbal ingredients consumed
by the third group (subsample 3). Cynara scolymus (arti-
choke) is the most consumed herbal ingredient by con-
sumers of all three groups (contained in 6.1, 7 and 8.6 %
of the PFS consumed respectively) and is followed by
green tea in the first group and by fennel in the other
two groups.
BMI differences between consumers and non-consumers
of the 5 most used herbal ingredients
Table 5 shows the BMI differences between consumers
and non-consumers of the top 5 herbal ingredients
consumed for “body weight reasons”, when using a)
subsample 1 or b) the entire survey sample. In the first
case, no significant differences were observed. However,
in the second case a greater proportion of consumers
of PFS containing artichoke (58.4 %) and green tea
(63.2 %) have a BMI ≥ 25 kg/m2 as compared to non-
consumers (49.1 and 49.7 % respectively; p = 0.019 and
p = 0.043 respectively).
Table 6 shows BMI differences between consumers
and non-consumers of the top 5 herbal ingredients con-
sumed by “dieters for overweight/obesity”, when using a)
the subsample 2 (“dieters") or b) the entire survey sam-
ple. In the subsample, the proportion of consumers with
BMI ≥ 25 is lower among consumers of Ananas comosus
(pineapple)-containing PFS (38.5 %) as compared to
non-consumers (81.8 %) (p = 0.000). In the full sample
the proportion of consumers with BMI ≥ 25 is greater
among those using artichoke-containing PFS (58.4 %)
than among non-consumers (49.1 %) (p = 0.019).
BMI differences among consumers and non-consumers
of herbal ingredients taken by the third group could not
be analysed due to the small size of the sample. Only BMI
differences among consumer and non-consumers of
artichoke were tested and they were not significant
(p = 0.826). Country comparisons could not be per-
formed either due to sample size restrictions.
Country distribution of the number of artichoke-containing
PFS used for body weight and other health reasons
Figure 3 shows the number of artichoke-containing PFS
used for body weight and other health reasons in each
country. The three first reasons for taking artichoke-
Garcia-Alvarez et al. BMC Complementary and Alternative Medicine  (2016) 16:254 Page 4 of 15
containing products were “body weight”, “stomach/di-
gestive function” and “cholesterol”. Spain was the coun-
try with more PFS consumed for body weight reasons
(47/79), followed by Germany (with 14/79). However, the
same total number of products were used for stomach/di-
gestive function, being most used in Germany (37/79),
followed by Romania (17/79). Cholesterol is the third
health reason reported by users of artichoke-containing
products, being most used in Germany (21/32).
Discussion
The analysis presented here provides an overview of the
herbal ingredients contained in PFS that were used by
specific consumers in six European countries, who
Table 1 Sample characteristics, overall and by response to question on “reasons” to take the PFS producta
Characteristics All categories Total (n = 2359) Did not respond body weight
(n = 2119, 89.8 %)
Responded body weightc
(n = 240, 10.2 %)
n % n % n % χ2 p-value*
Gender Males 1141 48.4 1055 49.8 86 35.8 0.000
Females 1218 51.6 1064 50.2 154 64.2
Age (years) 18-59 1764 74.8 1578 74.5 186 77.5 0.306
≥60 595 25.2 541 25.5 54 22.5
Country Finland 401 17.0 364 17.2 37 15.4 0.000
Germany 398 16.9 362 17.1 36 15.0
Italy 378 16.0 345 16.3 33 13.8
Romania 400 17.0 375 17.7 25 10.4
Spain 402 17.0 305 14.4 97 40.4
United Kingdom 380 16.1 368 17.4 12 5.0
BMI (kg/m2) <25 1185 50.2 1089 51.4 96 40.0 0.001
≥25 1174 49.8 1030 48.6 144 60.0
Education Low 249 10.6 223 10.5 26 10.8 0.109
Medium 1549 65.7 1379 65.1 170 70.8
High 561 23.8 517 24.4 44 18.3
Employment Currently employed 1357 57.5 1210 57.1 147 61.3 0.218
Other groups 1002 42.5 909 42.9 93 38.7
Dieting Not dieting for ove/obeb 2247 95.2 2074 97.9 173 72.1 0.000
Dieting for ove/obeb 112 4.8 45 2.1 67 27.9
Physical activity Low 1214 51.5 1067 50.4 147 61.3 0.006
Moderate 1033 43.8 950 44.8 83 34.6
High 112 4.7 102 4.8 10 4.2
Smoking habit Never smoker 1100 46.6 1005 47.4 95 39.6 0.032
Former smoker 544 23.1 488 23.0 56 23.3
Current smoker 715 30.3 626 29.5 89 37.1
Alcohol consumption 0- < 1 time/day 1398 82.5 1251 82.0 147 87.5 0.074
≥1 time/day 296 17.5 275 18.0 21 12.5
Mean SD Mean SD Mean SD t-test p-value*
Food frequency (times/day) Fruit 1.34 1.04 1.35 1.06 1.25 0.94 ns
Vegetable 0.95 0.91 0.94 0.91 1.01 0.93 ns
Bakery and pastries 0.49 0.96 0.51 0.99 0.3 0.62 0.002
Soft drinks 1.07 1.79 1.11 1.83 0.79 1.33 0.011
Fast food 0.09 0.26 0.09 0.27 0.08 0.14 ns
aQuestion asked: For what reason(s)/condition(s) did you take this product? (mark all that apply) - twenty possible options were available. Variable categories: 1)
did not respond “body weight”, 2) responded “body weight”; bOve/obe: overweight/obesity; cResponded “body weight” among other reasons
*p < 0.05 for significance
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Fig. 2 PFS Consumers “dieting for overweight/obesity” (%), by country
Fig. 1 PFS products taken for “body weight reasons” (% of total PFS reported), by country
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participated in the PlantLIBRA PFS Consumer Survey
2011. The herbal ingredients are identified in those PFS
consumers that a) use these products for body weight
reasons, b) are overweight/obesity dieters, and c) use
PFS for body weight reasons and are also dieting. The
study also explores the relationship between the use/
non-use of the top weight-loss PFS herbal ingredients
and self-reported BMI of survey participants.
The PFS consumers who take these products for weight
control are predominantly women, living in Spain, over-
weight and obese (with BMI ≥ 25), non-dieters, with low
physical activity, never smokers, low alcohol consumers,
and less frequent consumers of bakery, pastries and soft-
drinks. This profile suggests that individuals who use PFS
for body weight reasons are health conscious and may
turn to these products with the belief that this is a safe/in-
nocuous and effort-free strategy to lose or maintain
weight, a belief that other researchers have identified
[50, 51]. Other studies have reported dietary-supplement
consumer profiles with similar gender results to those of
the present study, but with disparate results for the other
factors [9, 44, 47, 52].
The present study also found that of the total 2874
PFS products consumed, 252 (8.8 %) products were re-
ported to be consumed for body weight reasons in the
previous 12 months by 240 PFS consumers of the total
sample n = 2359, i.e. a prevalence of weight-loss PFS
users of 10.2 %. In a US study, Blanck et al. (2007) re-
ported a prevalence of 8.7 % of past year use of “non-
prescription weight-loss supplements” (including dietary
supplements and natural or herbal weight loss aids not
prescribed by a doctor), using data from the 2002 US
National Physical Activity and Weight Loss Survey (n =
9,403). Of the products reported by past-year weight-
loss supplement users, 73.8 % contained a stimulant in-
cluding ephedra, bitter orange, caffeine, guaraná, and
kola nut [44]. In a study using data on CAM use from
the 2002 US National Health Interview Survey (NHIS)
Alternative Medicine Supplement (n = 31,044), Bertisch
et al. (2008) reported higher prevalence of “natural herbs
use” (between approximately 17 % and just over 20 %
depending on BMI category, with normal weight individ-
uals showing the highest rate); but this study focused on
CAM therapies use and did not specify the format in
which the natural herbs were used [45]. Another survey
of US adults, a computer-assisted telephone interview
conducted by the Center for Survey Research and Ana-
lysis at the University of Connecticut in 2005–2006,
reported a much higher prevalence of use: of the adults
who made a serious weight-loss attempt (n = 1,444),
Table 2 Top 20 herbal ingredients contained in the PFS taken by consumers, according to “body weight” reasona
PFS taken by those who responded “body weight”b PFS taken by those who did not respond “body weight”c
Herbal ingredients consumed PFS (n) % (CI 95 %) Herbal ingredients consumed PFS (n) % (CI 95 %)
Cynara scolymus (artichoke) 72 6.1 (4.7-7.4) Ginkgo biloba (ginkgo) 191 3.1 (2.6-3.5)
Camellia sinensis (green tea) 37 3.1 (2.1-4.1) Oenothera biennis (evening primrose) 184 2.9 (2.5-3.4)
Foeniculum vulgare (fennel) 34 2.9 (1.9-3.8) Panax ginseng (ginseng) 160 2.6 (2.2-2.9)
Vitis vinifera (grapevine) 23 1.9 (1.2-2.7) Aloe vera (aloe) 132 2.1 (1.8-2.5)
Ananas comosus (pineapple) 21 1.8 (1.0-2.5) Valeriana officinalis (valerian) 123 2.0 (1.6-2.3)
Taraxacum officinale (dandelion) 21 1.8 (1.0-2.5) Cynara scolymus (artichoke) 101 1.6 (1.3-1.9)
Pimpinella anisum (aniseed) 19 1.6 (0.9-2.3) Echinacea purpurea (echinacea) 100 1.6 (1.3-1.9)
Rosmarinus officinalis (rosemary) 19 1.6 (0.9-2.3) Foeniculum vulgare (fennel) 98 1.6 (1.3-1.9)
Linum usitatissimum (flax) 17 1.4 (0.8-2.1) Melissa officinalis (lemon balm) 95 1.5 (1.2-1.8)
Vaccinium myrtillus (bilberry) 17 1.4 (0.8-2.1) Glycine max (soy bean) 91 1.5 (1.2-1.8)
Citrus limon (lemon) 15 1.3 (0.6-1.9) Vaccinium myrtillus (bilberry) 83 1.3 (1.0-1.6)
Raphanus sativus (radish) 15 1.3 (0.6-1.9) Echinacea angustifolia (echinacea) 77 1.2 (1.0-1.5)
Urtica dioica (common nettle) 15 1.3 (0.6-1.9) Harpagophytum p. (devil’s claw) 75 1.2 (0.9-1.5)
Zingiber officinale (ginger) 15 1.3 (0.6-1.9) Passiflora incarnata (passionflower) 74 1.2 (0.9-1.5)
Matricaria chamomilla (Hungarian camomile) 15 1.3 (0.6-1.9) Zingiber officinale (ginger) 74 1.2 (0.9-1.5)
Malus pumila (apple) 14 1.2 (0.6-1.8) Allium sativum (garlic) 71 1.1 (0.9-1.4)
Aloe vera (aloe) 13 1.1 (0.5-1.7) Pimpinella anisum (aniseed) 70 1.12 (0.9-1.4)
Equisetum arvense (horsetail) 13 1.1 (0.5-1.7) Glycyrrhiza glabra (licorice) 67 1.1 (0.8-1.3)
Fucus vesiculosus (kelp) 13 1.1 (0.5-1.7) Oenothera spec (evening primrose) 65 1.0 (0.8-1.3)
Olea europaea (olive tree) 13 1.1 (0.5-1.7) Mentha piperita (peppermint) 64 1.0 (0.8-1.3)
aQuestion asked: For what reason(s)/condition(s) did you take this product? (mark all that apply) - twenty possible options were available. bThose who responded
“body weight” i.e. Subsample 1; at least one of the options chosen included “body weight”. cNeither of the options chosen included “body weight”
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33.9 % reported ever having used a “dietary supple-
ment for weight loss” (including “over-the-counter ap-
petite suppressants, herbal products, or weight-loss
supplements”, although not distinguishing between
them) [9]. Lastly, in their recent study (n = 2,732) in
the city of Pelotas, Brazil, Machado et al. (2012) re-
ported that the prevalence of use of “substances for
weight-loss” was 12.8 %; however, these substances in-
cluded teas, dietary supplements (unspecified) and
medicines [47]. It is important to mention that all
these studies were conducted in general populations,
as opposed to PFS consumers.
A comparison of results among the scarce publications
evaluating the use of weight-loss supplements at the
population level is limited. The studies varied in the ter-
minology used (concepts and definitions ranged between
“natural herbs”, “non-prescription weight loss supple-
ments”, or “substances for weight-loss”), study designs,
sample sizes, and data collection methodology. The
present study is the first study to evaluate the use of
herbal weight-loss supplements in consumers of PFS in
six European countries, having harmonised the termin-
ology and methods used across countries.
The present study estimated the prevalence of dieting
for overweight/obesity in the PlantLIBRA Survey of PFS
consumers [43]: 4.8 % (n = 113) of 2359 PFS consumers
in the six European countries. Similar rates were re-
ported in one study [44], where 4.4 % of those currently
trying to maintain the same weight were users of
weight-loss dietary supplements during the past year;
however, 16.1 % of those currently trying to lose weight
reported past-year use of these products (around a four-
Table 4 Top 10 herbal ingredients contained in PFS taken by
consumers responding “body weight” while “dieting-for-
overweight/obesity”a
Herbal ingredients consumed PFS (n) % (CI 95 %)
Cynara scolymus (artichoke) 27 8.6 (5.5-11.7)
Foeniculum vulgare (fennel) 13 4.1 (1.9-6.3)
Ananas comosus (pineapple) 11 3.5 (1.5-5.5)
Matricaria chamomilla (Hungarian camomile) 10 3.2 (1.2-5.1)
Taraxacum officinale (dandelion) 9 2.9 (1.0-4.7)
Fucus vesiculosus (kelp) 8 2.5 (0.8-4.3)
Raphanus sativus (radish) 8 2.5 (0.8-4.3)
Rosmarinus officinalis (rosemary) 8 2.5 (0.8-4.3)
Camellia sinensis (green tea) 7 2.2 (0.6-3.9)
Carica papaya (papaya) 7 2.2 (0.6-3.89)
aSubsample 3: at least one of the options chosen included “body weight” and
at least one of the options chosen included “dieting-for-overweight/obesity”
Table 3 Top 20 herbal ingredients contained in PFS taken by consumers who “are/are not” “dieting for overweight/obesity”a
Responded “Dieting for ove/obe”b Did not respond “Dieting for ove/obe”c
Herbal ingredients consumed PFS (n) % (CI 95 %) Herbal ingredients consumed PFS (n) % (CI 95 %)
Cynara scolymus (artichoke) 34 7.0 (6.4-7.7) Oenothera biennis (Evening primrose) 193 2.8 (2.4-3.2)
Foeniculum vulgare (fennel) 17 3.5 (2.3-3.2) Ginkgo biloba (ginkgo) 191 2.7 (2.3-3.1)
Taraxacum officinale (dandelion) 14 2.9 (2.0-2.8) Panax ginseng (ginseng) 166 2.4 (2.0-2.8)
Ananas comosus (pineapple) 13 2.7 (1.7-2.5) Aloe vera (aloe) 143 2.1 (1.7-2.4)
Matricaria chamomilla (Hungarian camomile) 11 2.3 (1.6-2.4) Cynara scolymus (artichoke) 139 2.0 (1.7-2.3)
Camellia sinensis (green tea) 10 2.1 (1.4-2.1) Valeriana officinalis (valerian) 120 1.7 (1.4-2.0)
Rosmarinus officinalis (rosemary) 10 2.1 (1.3-2.0) Foeniculum vulgare (fennel) 115 1.7 (1.3-2.0)
Fucus vesiculosus (kelp) 9 1.9 (1.1-1.8) Echinacea purpurea (echinacea) 102 1.5 (1.2-1.8)
Paullinia cupana (guarana) 9 1.9 (1.1-1.8) Melissa officinalis (lemon balm) 102 1.5 (1.2-1.8)
Vitis vinifera (grapevine) 9 1.9 (1.1-1.7) Glycine max (soy bean) 98 1.4 (1.1-1.7)
Raphanus sativus (radish) 8 1.7 (1.1-1.7) Vaccinium myrtillus (bilberry) 95 1.4 (1.1-1.7)
Sambucus nigra (elder) 8 1.7 (0.9-1.6) Zingiber officinale (ginger) 87 1.3 (1.0-1.5)
Carica papaya (papaya) 7 1.5 (0.9-1.5) Pimpinella anisum (aniseed) 82 1.2 (0.9-1.4)
Citrus limon (lemon) 7 1.5 (0.8-1.4) Echinacea angustifolia (Echinacea) 79 1.1 (0.9-1.4)
Pimpinella anisum (aniseed) 7 1.5 (0.8-1.4) Vitis vinifera (grapevine) 78 1.1 (0.9-1.4)
Silybum marianum (milk thistle) 7 1.5 (0.8-1.4) Camellia sinensis (green tea) 77 1.1 (0.9-1.4)
Smilax officinalis (sarsaparilla) 7 1.5 (0.8-1.4) Linum usitatissimum (flax) 75 1.1 (0.8-1.3)
Asparagus officinalis (asparagus) 6 1.2 (0.8-1.4) Passiflora incarnate (passionflower) 75 1.1 (0.8-1.3)
Equisetum spec. (horsetail & scouring rush) 6 1.2 (0.8-1.3) Harpagophytum p. (devil’s claw) 74 1.1 (0.8-1.3)
Cassia senna (senna) 5 1.0 (0.8-1.3) Allium sativum (garlic) 73 1.1 (0.8-1.3)
aQuestion asked: Are you following any special diet(s) which would cause you to avoid certain foods? (mark all that apply) – sixteen possible options were available;
bSubsample 2; at least one of the options chosen included “overweight/obesity”. cNeither of the options chosen included “overweight/obesity”
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fold higher rate). In addition, Pillitteri et al. (2008) ob-
served much higher rates, reporting that of the adults
who made a serious weight-loss attempt (n = 1,444),
33.9 % had used a dietary supplement for weight loss
[9]. These findings are similar to those of Machado et al.
(2012), who reported a prevalence of 48.4 % for use of
weight loss supplements in those who tried to lose
weight [47]. Again, comparisons between studies are dif-
ficult because of study limitations in terms of design,
terms used and data collection procedures.
This is the first study in a sample of PFS consumers
from six EU countries that has identified the herbal in-
gredients contained in products used by “consumers for
weight control”, by “overweight/obese dieters” and by
“overweight/obese consumers who are simultaneously
consuming PFS for weight control and dieting for weight
control”. Artichoke was the herbal ingredient that ap-
peared in the greatest number of PFS consumed in all
three groups (6.1, 7 and 8.6 % respectively); however,
these results might be driven by the high use of these
artichoke-containing products reported in Spain and
Germany (see the discussion further down). In addition,
green tea (3.1 %) and fennel (2.9 %) were second and third
in the first group. Fennel (3.5 %) and dandelion (2.9 %)
were second and third in the second group. Lastly, fennel
(4.1 %) and pineapple (3.5 %) were second and third in the
third group. To our knowledge, only one recent US study
has reported the actual herbal ingredients contained in
weight-loss supplements and the prevalence of users [44].
They reported different herbal ingredients, with almost
74 % using a product classified as a stimulant, more than
half (55 %) consuming product containing Ephedra sinica
(ephedra or ma huang), one in 15 used a product contain-
ing Citrus aurantium (bitter orange), and one in 10 took
Garcinia cambogia (hydroxycitric acid); other active
herbal ingredients, such as conjugated linoleic acid and
Ilex paraguariensis (yerba mate), were in very few of the
products reported in the study [44].
Some literature on the effectiveness of artichoke for
weight loss reveals that the scientific evidence is
Table 5 BMI differences between consumers and non-consumers of the top 5 herbal ingredients consumed for “body weight” reasonsa
BMI
<25 kg/m2 ≥25 kg/m2
Top 5 herbal ingredients consumed for “body weight” Consumption group n % n % Chi2
p-value*
a) When using only the subsample 1b (n = 240)
Cynara scolymus (artichoke) Consumers 24 33.3 48 66.7 0.168
Non-consumers 72 42.9 96 57.1
Foeniculum vulgare ssp. (fennel) Consumers 15 40.5 22 59.5 0.942
Non-consumers 81 39.9 122 60.1
Camellia sinensis (green tea) Consumers 17 50 17 50 0.199
Non-consumers 79 38.3 127 61.7
Vitis vinifera (grapevine) Consumers 6 26.1 17 73.9 0.152
Non-consumers 90 41.5 127 58.5
Ananas comosus (pineapple) Consumers 10 47.6 11 52.4 0.456
Non-consumers 86 39.3 133 60.7
b) When using the entire sample of consumers (n = 2359)
Cynara scolymus (artichoke) Consumers 72 41.6 101 58.4 0.019
Non-consumers 1113 50.9 1073 49.1
Foeniculum vulgare ssp. (fennel) Consumers 71 53.8 61 46.2 0.401
Non-consumers 1114 50 1113 50
Camellia sinensis (green tea) Consumers 32 36.7 55 63.2 0.043
Non-consumers 1142 50.3 1130 49.7
Vitis vinifera (grapevine) Consumers 43 49.4 44 50.6 0.878
Non-consumers 1142 50.3 1130 49.7
Ananas comosus (pineapple) Consumers 21 60 14 40 0.244
Non-consumers 1164 50.1 1160 49.9
aDifferences are analysed when using a) subsample 1 (respondents of “body weight”) and b) the entire survey sample; bSubsample 1: respondents of “body
weight”; *p < 0.05 for significance
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“insufficient to guarantee the efficacy and safety for
treating obesity but could be useful to treat some of its
comorbidities (i.e. hyperlipidemia)” [53]. In their review,
de Villar et al. (2003) reported that it is frequently used
in slimming products and as a diuretic [53]. According
to the recent “Assessment report on Cynara scolymus L.,
folium”, by the European Medicines Agency (2011), other
indications of traditional use (which is how it is used in
Spain) include arteriosclerosis and hyperlipidemia [54].
The same report also states that “the antioxidative, hepa-
toprotective and choleretic effects of artichoke leaf ex-
tracts as well as lipid-lowering and anti-atherogenic
activity with increased elimination of cholesterol and
inhibition of hepatocellular de novo cholesterol biosyn-
thesis have been demonstrated in various in vitro and
in vivo test systems [54].
Only one publication included pineapple as an ingredi-
ent of popularly consumed weight loss products, in
Spain [53]. The authors outlined the main therapeutic
indications/recommendations of pineapple at that time
(2003), distinguishing the “true” ones (burns, skin le-
sions) from the “traditional-use” ones (dyspepsia, arth-
ralgia, arthritis, stomatitis, cellulitis, exocrine pancreatic
insufficiency and obesity; including a comment of “mild
diuretic effect”), and concluded that scientific evidence
for weight-loss effectiveness is “untested/non-existent”
[53]. However, in a very recent publication [55], the au-
thors concluded that there might be an effect at cell
level, which may be a potent modulator of obesity.
Finally, no publication was found including fennel as
an ingredient of weight loss supplements, despite the ex-
tensive and recent scientific literature describing its uses
and properties [56, 57]. A hypothesis for the high preva-
lence of consumption by our consumers using PFS for
weight control and dieters might involve the fact that
some of the properties attributed to fennel are to “im-
prove digestion”, “prevent bloating” and as “flavour cor-
rector” i.e. it might be accompanying other substances in
Table 6 BMI differences between consumers and non-consumers of the top 5 herbal ingredients used by “dieters for overweight/
obesity”a
BMI
<25 kg/m2 ≥25 kg/m2
Top 5 herbal ingredients consumed by “dieters for
overweight/obesity”
Consumption group n % n % Chi2
p-value*
a) When using only the subsample 2b (n = 112)
Cynara scolymus (artichoke) Consumers 9 26.5 25 73.5 0.590
Non-consumers 17 21.8 61 78.2
Foeniculum vulgare ssp. (fennel) Consumers 5 29.4 12 70.6 0.511
Non-consumers 21 22.1 74 77.9
Taraxacum officinale (dandelion) Consumers 3 21.4 11 78.6 0.866
Non-consumers 23 23.5 75 76.5
Ananas comosus (pineapple) Consumers 8 61.5 5 38.5 0.000
Non-consumers 18 18.2 81 81.8
Matricaria chamomilla (chamomile) Consumers 1 9.1 10 90.9 0.243
Non-consumers 25 24.8 76 75.2
b) When using the entire sample of consumers (n = 2359)
Cynara scolymus (artichoke) Consumers 72 41.6 101 58.4 0.019
Non-consumers 1113 50.9 1073 49.1
Foeniculum vulgare ssp. (fennel) Consumers 71 53.8 61 46.2 0.401
Non-consumers 1114 50 1113 50
Taraxacum officinale (dandelion) Consumers 39 48.8 41 51.3 0.787
Non-consumers 1146 50.3 1133 49.7
Ananas comosus (pineapple) Consumers 21 60 14 40 0.244
Non-consumers 1164 50.1 1160 49.9
Matricaria chamomilla (chamomile) Consumers 32 47.8 35 52.2 0.681
Non-consumers 1153 50.3 1139 49.7
aDifferences are analysed when using a) subsample 2 (consumers responding to be “dieting for overweight/obesity”) and b) the entire survey sample;
bSubsample 2: consumers responding to be “dieting for overweight/obesity”; *p < 0.05 for significance
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weight-loss multi-ingredient supplements to improve di-
gestion, neutralize intestinal gas formation and enhance
their flavour [58]. Moreover, like for pineapple, adver-
tisements promoting fennel-containing products as a
slimming aid on the Internet are numerous, which may
provide an additional explanation.
In Spain, the country with the highest prevalence of
“body weight reason respondents” (21.5 %) and “dieters”
(17.4 %) and where artichoke-containing products were
most used for body weight reasons (47/79 PFS), results
are consistent with the traditional use of artichoke as ad-
juvant of weight loss treatments, to allow a fat diet in
the treatment of mild to moderate hyperlipidaemia (for
reducing cholesterol) [54]. These results are also in line
with some reports in the literature, such as the “White
Book of herbal shops and medicinal plants”, a report
about the situation of the Spanish herbal shop sector
[59], in which the authors report that the top-selling
products are food supplements (29 %) followed by
weight control products (28 %). We explored other rea-
sons for the use of artichoke in the six survey countries
and there is agreement with the recommendations of
use for stomach/digestive function and cholesterol
(highest in Germany) (Fig. 3). In Germany, artichoke is
used in traditional herbal medicinal products used to
promote digestion (against dyspepsia, digestive com-
plaints) [54]. Moreover, artichoke has been used in trad-
itional medicine for centuries all over Europe as a
specific liver and gallbladder remedy and several herbal
drugs based on the plant are used as well for high choles-
terol and digestive and liver disorders [54]. Other uses
around the world include treatment for dyspepsia and
chronic albuminuria [54]. We cannot know at this stage
the health reasons behind the different prevalence of con-
sumption of the same herbal ingredient across the six
countries involved in our study, because of the low con-
sumption levels observed in the different sample groups.
In order to be able to discriminate more easily, we would
need to have a higher concentration of consumers of a
single product containing a particular herbal ingredient
consumed for a single health condition. We could
hypothesize that these differences may result from differ-
ent regulatory restrictions between the countries (i.e. the
same herbal ingredient might be used in PFS or in herbal
medicinal products), market consumption trends, market-
ing strategies related to traditional/cultural beliefs, etc.
Fig. 3 Number of Cynara scolymus (artichoke)-containing PFS used for body weight and other health reasons, by country
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However, further research is required to prove these hy-
potheses, involving a long-term prospective study design,
a larger sample size, market, regulatory, and anthropo-
logical data, as well as, stratification by gender, season of
the year, to name a few explanatory variables.
Our results show that, when the entire survey sample
was used (n = 2359) to increase the power of the com-
parison (Tables 5 and 6), significant BMI differences
were observed between consumers and non-consumers
of artichoke. Also in this entire sample, differences were
observed in BMI between consumers and non-consumers
of green tea (third most consumed herbal ingredient of re-
spondents of “body weight reasons”). In both cases, more
consumers than non-consumers of each herbal ingredient
were overweight/obese (BMI ≥ 25 kg/m2). Again, even
though we could not analyse the products consumed in
each country, and considering the high use of artichoke in
the Spanish sample (Fig. 3), we hypothesized that the
Spanish data could be influencing these differences ob-
served through the Chi-square analysis. In order to further
try and clarify this hypothesis, we performed lineal Spear-
man’s correlation analyses (not shown) using all 3 samples
(entire survey, “respondents of body weight”, and “dieters
for overweight/obesity”) between the variables of “con-
sumption/non-consumption of the herbal ingredients of
the most consumed PFS in each sample” and “BMI”; BMI
was first included as a continuous variable, then as a di-
chotomous variable (BMI < 25; ≥25 kg/m2) and lastly,
as a categorical variable of 3 categories (BMI < 25; ≥25-
30; >30 kg/m2). Only the following two results yielded
in these analyses were significant for products contain-
ing artichoke: 1) with BMI continuous, consumers of
products containing artichoke tended to have a higher
BMI (coefficient = 0.070, significance = 0.001); 2) with
BMI dichotomous, consumers of products containing
artichoke tended to be in the highest BMI range (coeffi-
cient = 0.048, significance = 0.019). These results show
that, although significant, the correlations were not
very strong (not very close to 1). This could indicate
that the Spanish data was not influencing the global re-
sults as far as artichoke was concerned in the entire
survey sample.
As for the “dieters” subsample only (n = 112), results
presented in Table 6 show very significant BMI differ-
ences for products containing Ananas comosus (pine-
apple), with consumers having higher rates of normal
weight (BMI < 25 kg/m2) than non-consumers. These re-
sults were in line with those observed later in the correl-
ation analyses (not shown), which yielded the following
significant results: with all 1) BMI continuous, 2) BMI
dichotomous, and 3) BMI categorical, consumers of
products containing pineapple tended to be in the lowest
ranges of BMI, i.e. 1) coefficient = -0.250, significance =
0.008 2) coefficient = -0.329, significance = 0.000, and 3)
coefficient = -0.324, significance = 0.000, respectively).
These correlation results were very significant (significance
< 0.01) and also stronger (closer to -1) than those for
artichoke.
Finally, we took a step further and, only using the
Spanish data, we performed some Chi-square tests to
analyze differences in the relationship between dichot-
omous BMI and the consumption/non-consumption of
the 5 herbal ingredients included in Tables 5 (respon-
dents of “body weight”) and 6 (“dieters”) (not shown).
The differences observed were only significant for pine-
apple in both subsamples, i.e. again, a higher percent-
age of consumers of products containing pineapple
had a BMI < 25 kg/m2, but to a further extent in
“dieters” vs. “respondents of body weight” (p = 0.000
vs. p = 0.012, respectively). These results concerning
the consumption of pineapple-containing PFS by the
“dieters” subsample could suggest an influence of the
Spanish data on the global results.
Summarising, pineapple contained in products con-
sumed by “dieters” show the strongest relationship with
BMI, with those declaring to consume them tending to
have a lower BMI or tending to belong to the lowest
BMI range. The global results observed for this relation-
ship are possibly influenced by its higher consumption
in Spain. However, we do not know why this is happen-
ing or if there is an association influenced by other fac-
tors, and we cannot infer causality from these results
due to the cross-sectional nature of the survey. Bertisch
et al. (2008), who analysed the relationship between
obesity and the use of CAM (including natural herbs),
reported that adults with obesity had similar prevalence
of use of natural herbs compared to normal-weight indi-
viduals, and after adjustment by some factors they were
generally less likely to use most individual CAM modal-
ities [45]. Nevertheless, Bertisch et al.’s study and our
study are not comparable because they evaluated the
overall use of natural herbs as a CAM modality in the
general population, instead of the use of herbal ingredi-
ents among PFS consumers. To our knowledge, our
study is the first study that has tested BMI differences
between consumers and non-consumers of particular
herbal ingredients contained in PFS.
The present study has several limitations. The survey
was not designed to assess weight loss. All data were
self-reported, allowing the possibility of misreporting -al-
though with regards to the products, the interviewers
verified the packaging of approximately 50 % of them.
There exists the possibility of misclassification of a prod-
uct as a PFS when it might be in fact an herbal medi-
cinal product, due to the unawareness by the consumer
of the legal status of the product or by a post-data-
collection change of status of the product. In addition,
the survey did not collect composition/label data (mostly
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unavailable), therefore, dosages of herbal ingredients
could not be calculated for BMI/dosage analyses. The
definition of the product “plant food supplement” is so
specific that results can really only be compared with re-
sults from other studies with this definition. The cross-
sectional nature of the survey does not allow inference
of causality. The design of the survey (only including
PFS consumers and quota sampling) does not allow ei-
ther the weighting of the data, the extrapolation of re-
sults to the general population or the comparison with
general population studies. Finally, the survey had a
small sample size that allowed limited stratification and
no regression analyses for assessing the association
between BMI and herbal ingredients consumption vs.
non-consumption and identifying significant predictors.
This study has some unique strengths. It is the first
study that has identified the herbal ingredients most
consumed by PFS consumers from six European coun-
tries who reported taking these products for reasons of
“body weight” or who were “dieting for overweight/obes-
ity”. In addition, the “PFS product” was very clearly de-
fined and differentiated from other herbal products,
which will allow direct comparison with future studies
on weight loss and PFS consumption that might be con-
ducted. Finally, the study has identified some of the
many possibilities for future research to try and explain
the differences in the use of weight-loss herbal supple-
ments across national markets within the EU. This
would encourage, for example, further research into the
many aspects by which the different types of herbal
products used in weight-loss/control can be differenti-
ated, ideally using purposely collected data at the na-
tional and/or European levels.
Conclusions
A comparison of results among the limited publications
evaluating the use of weight-loss supplements at the
population level is limited. Nevertheless every hint is im-
portant in finding out which are the self-treatment strat-
egies used by overweight/obese individuals in European
countries. Although limited by a small sample size, our
study represents a first attempt at analysing such data in
six EU countries. Our findings should encourage the
conduction of further studies on this topic, including
long-term and large sample-sized studies, ideally con-
ducted in the general population. These studies would
include, for example, prospective/cohort studies collect-
ing detailed data on ingredients amounts/dosages, and
identifying patterns and reasons of consumption for de-
termining health outcomes (such as obesity); or studies
interlinking data with national markets of botanical prod-
ucts (including weight-loss products); or regional/national
nutritional/health/CAM-use surveys collecting data on the
consumption of botanical products (including weight-loss
ones); or national consumer surveys and health know-
ledge/perception surveys collecting data on these products.
This additional information would help elucidate the many
unknowns about the marketing, consumption and effect-
iveness of PFS, in particular, those specifically used as a
strategy for body weight control.
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